- This event has passed.
CTN Webinar: Potential Benefits of Increased Use of Prescription Monitoring Programs
April 27, 2017 @ 1:00 pm - 2:00 pm
National Drug Abuse Treatment Clinical Trials Network Webinar titled Potential Benefits of Increased Use of Prescription Monitoring Programs presented by Dr. Thomas Alfieri on Thursday, April 27, 2017 from 1:00 – 2:00 PM EDT.
Event Description:
Purdue Pharma L.P., Virginia Governor Terry McAuliffe and the Virginia Secretary of Health and Human Resources announced the formation of a public-private partnership to enhance utilization of the state prescription monitoring program (PMP) as part of the solution to address the opioid crisis. The Commonwealth of Virginia will connect the state PMP to the electronic health records (EHR) used by Virginia prescribers and pharmacists to make information from the PMP an integral part of the patient workflow when prescribing or dispensing controlled substances. The goal is to improve the performance, access and usability of the PMP program data for 18,000 prescribers and 400 pharmacies in the Commonwealth of Virginia by the end of 2017.
The Virginia PMP provides to authorized users a patient’s prescription history for Schedule II – V prescriptions for the prior 12 months as reported by all Virginia pharmacies and by out-of-state pharmacies delivering to people in Virginia. Additionally, the PMP prescription report informs clinical decision-making to help prevent or stop harm from duplicate drug therapy, prescription drug misuse, abuse and diversion.
This presentation will outline the potential benefits of PMP use, and explore ways that these benefits can be measured.
Presenter Information:
Thomas Alfieri, PhD, is a director of strategic research at Purdue Pharma L.P., where he is responsible for developing and executing a program of collaborative research partnerships aimed at improving pain management and decreasing opioid misuse. Current research projects include examining the role of prescription monitoring programs in preventing opioid misuse, the impact of medicine disposal initiatives on public health, and the effect of wearable health technologies on patient outcomes among chronic pain patients. He earned his doctorate in social psychology from New York University and advanced degrees in statistics and operations research from NYU’s Stern School of Business. Dr. Alfieri has spent the majority of his professional career designing research projects in a variety of fields including health outcomes, consumer perception, and marketing.
For information on how to register, please contact the Northeast Node.